# To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy

> **NCT07634991** · PHASE4 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 76 (estimated)

## Conditions studied

- Diabetic Retinopathy (DR)

## Interventions

- **DRUG:** N Acetyl cysteine, 1200mg (high dose)

## Key facts

- **NCT ID:** NCT07634991
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-10
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07634991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07634991, "To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07634991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*